Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in wisconsin: a statewide population-based study
Subra Kugathasan(Children's Healthcare of Atlanta), David G. Binion(University of Pittsburgh), Issam Halabi(University of Minnesota), William San Pablo(Children's Hospital of Wisconsin), Colin D. Rudolph(Greenville College), Sally Weisdorf‐Schindele(Aspirus Wausau Hospital), Robert H. Judd(Mayo Clinic), Gregorz Telega(University of Wisconsin–Madison), Maria T. Rivera-Bennett(Children's Hospital of Wisconsin), Steven L. Werlin(Greenville College), Chris W. Brown(Medical College of Wisconsin), Farhat Ullah Khan(Aspirus Wausau Hospital), Alfonso Martínez(Gundersen Health System), Jean Perrault(Mayo Clinic in Arizona), Janice B. Heikenen(Aspirus Wausau Hospital), Raymond G. Hoffmann(Children's Hospital of Wisconsin), Roger Park(Children's Hospital of Wisconsin), Ellen L. Blank(Marshfield Clinic), Michael R. Yaffe(Medical College of Wisconsin)
Cited by 614
Related Papers
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k
Hereditary Pancreatitis and the Risk of Pancreatic Cancer
|JNCI Journal of the National Cancer Institute|1997|986
Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in Children
|Gastroenterology|2006|872
A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients
|Genome Medicine|2017|787